When Orphan Drugs Make All the Difference

Published: Mar 3, 2016
Only 5% of rare diseases have treatments. What difference does that make to patients?

Orphan drugs are growing in importance worldwide. However, bringing an orphan drug to market unique challenges and considerations. Overcoming these challenges requires the cooperation of clinical trial investigators, drug manufacturers, local and national governments and more.

This article will discuss:

  • Where to start in overcoming these challenges
  • Possible secondary and more profitable use of an orphan drug
  • The process of holding clinical trials
  • Ethical and practical considerations
Author
World Courier
World Courier

The World Courier content team, in partnership with subject matter experts throughout our business, brings you thought leadership about global specialty and emergency logistics, clinical trial logistics, pharmaceutical storage and distribution, personalized supply chain, such as direct-to-patient and cell & gene therapy logistics, temperature control solutions and quality management standards.